(Q46972223)

27 December 2017

title

Fibroblast activation protein (FAP) is upregulated in myelomatous bone and supports myeloma cell survival (English)

1 reference

27 December 2017

3

Bart Barlogie

1 reference

27 December 2017

6

Shmuel Yaccoby

1 reference

27 December 2017

Yun Ge

1

1 reference

27 December 2017

Fenghuang Zhan

series ordinal

2

1 reference

27 December 2017

Joshua Epstein

series ordinal

4

1 reference

27 December 2017

John Shaughnessy

series ordinal

5

1 reference

27 December 2017

language of work or name

English

0 references

publication date

1 April 2006

1 reference

27 December 2017

British Journal of Haematology

published in

1 reference

27 December 2017

volume

133

1 reference

27 December 2017

issue

1

1 reference

27 December 2017

page(s)

83-92

1 reference

27 December 2017

Osteoclasts enhance myeloma cell growth and survival via cell-cell contact: a vicious cycle between bone destruction and myeloma expansion

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2006.05976.X

PT-100, a small molecule dipeptidyl peptidase inhibitor, has potent antitumor effects and augments antibody-mediated cytotoxicity via a novel immune mechanism.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2006.05976.X

The tumor microenvironment: focus on myeloma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2006.05976.X

Consequences of interactions between the bone marrow stroma and myeloma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2006.05976.X

Regulation of fibroblast migration on collagenous matrix by a cell surface peptidase complex

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2006.05976.X

Seprase promotes rapid tumor growth and increased microvessel density in a mouse model of human breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2006.05976.X

Fibroblast activation protein: differential expression and serine protease activity in reactive stromal fibroblasts of melanocytic skin tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2006.05976.X

Fibroblast activation protein-alpha and dipeptidyl peptidase IV (CD26): cell-surface proteases that activate cell signaling and are potential targets for cancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2006.05976.X

A novel protease-docking function of integrin at invadopodia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2006.05976.X

Involvement of chemokine receptors in breast cancer metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2006.05976.X

Metastasis to bone: causes, consequences and therapeutic opportunities

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2006.05976.X

Molecular Mechanisms of Bone Metastasis and Therapeutic Implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2006.05976.X

Fibroblast activation protein, a dual specificity serine protease expressed in reactive human tumor stromal fibroblasts

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2006.05976.X

Multiple myeloma disrupts the TRANCE/ osteoprotegerin cytokine axis to trigger bone destruction and promote tumor progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2006.05976.X

The stromal derived factor-1/CXCL12-CXC chemokine receptor 4 biological axis in non-small cell lung cancer metastases

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2006.05976.X

FAPalpha, a surface peptidase expressed during wound healing, is a tumor suppressor

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2006.05976.X

Pathogenesis of myeloma bone disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2006.05976.X

Mechanisms of bone metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2006.05976.X

The role of the Wnt-signaling antagonist DKK1 in the development of osteolytic lesions in multiple myeloma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2006.05976.X

Significance analysis of microarrays applied to the ionizing radiation response

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2006.05976.X

Myeloma interacts with the bone marrow microenvironment to induce osteoclastogenesis and is dependent on osteoclast activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2006.05976.X

Antimyeloma efficacy of thalidomide in the SCID-hu model

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2006.05976.X

Cancer and the microenvironment: myeloma-osteoclast interactions as a model

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2006.05976.X

Global gene expression profiling of multiple myeloma, monoclonal gammopathy of undetermined significance, and normal bone marrow plasma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2006.05976.X

Toward the identification of distinct molecular and clinical entities of multiple myeloma using global gene expression profiling

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2006.05976.X

Gene expression profiling of human plasma cell differentiation and classification of multiple myeloma based on similarities to distinct stages of late-stage B-cell development

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2006.05976.X

10.1111/J.1365-2141.2006.05976.X

21 January 2018

Identifiers

DOI

1 reference

27 December 2017

1 reference

27 December 2017